Upregulated ATM gene expression and activated DNA crosslink-induced damage response checkpoint in fanconi anemia: Implications for carcinogenesis

Molecular Medicine

Volumn 14, Issue 3-4, 2008, Pages 167-174

  Yamamoto, Kazuhiko ^a,b   Nihrane, Abdallah ^a,b   Aglipay, Jason ^c   Sironi, Juan ^c   Arkin, Steven ^a,b   Lipton, Jeffrey M ^a,b   Ouchi, Toru ^c,d   Liu, Johnson M ^a,b  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BIOLOGICAL MARKER; DNA; DOUBLE STRANDED DNA; FANCONI ANEMIA GROUP A PROTEIN; GAMMA H2AX PROTEIN; MITOMYCIN C; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; CARCINOGENESIS; CELL MUTANT; CONTROLLED STUDY; CROSS LINKING; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; FANCONI ANEMIA; FIBROBLAST; GENE ACTIVATION; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IRRADIATION; PRIORITY JOURNAL; UPREGULATION;

ADULT; ANIMALS; APOPTOSIS; CELL CYCLE; CELL CYCLE PROTEINS; CELLS, CULTURED; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 41649085578     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00122.Yamamoto     Document Type: Article

References (39)

1. Liu JM, Dokal I (2006) Constitutional aplastic anemias. In Clinical Hematology (Young NS, Gerson SL, High KA, eds.), Elsevier.
2. Niedernhofer LJ, Lalai AS, Hoeijmakers JH (2005) Fanconi anemia (cross)linked to DNA repair. Cell 123:1191-8.
3. Wang W (2007) Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat. Rev. Genet. 8:735-48.
4. Garcia-Higuera I, Taniguchi T, Ganesan S, Meyn MS, Timmers C, Hejna J, Grompe M, D'Andrea AD (2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell 7:249-62.
5. Sims AE, et al. (2007) FANCI is a second monoubiquitinated member of the Fanconi anemia pathway. Nat. Struct. Mol. Biol. 14:564-7.
6. Stewart G, Elledge SJ (2002) The two faces of BRCA2, a FANCtastic discovery. Mol. Cell 10:2-4.
7. D'Andrea AD, Grompe M (2003) The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer 3:23-34.
8. Rothfuss A, Grompe M (2004) Repair kinetics of genomic interstrand DNA cross-links: evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell Biol. 24:123-34.
9. Rosenberg PS, Greene MH, Alter BP (2003) Cancer incidence in persons with Fanconi anemia. Blood 101:822-6.
10. Kutler DI, et al. (2003) High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch. Otolaryngol. Head Neck Surg. 129:106-12.
11. Kutler DI, et al. (2003) Human papillomavirus DNA and p53 polymorphisms in squamous cell carcinomas from Fanconi anemia patients. J. Natl. Cancer Inst. 95:1718-21.
12. van Zeeburg HJ, et al. (2005) Generation and molecular characterization of head and neck squamous cell lines of Fanconi anemia patients. Cancer Res. 65:1271-6.
13. Zhou BB, Elledge SJ (2000) The DNA damage response: putting checkpoints in perspective. Nature 408:433-9.
14. Kastan MB, Lim DS (2000) The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 1:179-86.
15. Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499-506.
16. Bartkova J, et al. (2005) DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434:864-70.
17. Gorgoulis VG, et al. (2005) Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434:907-13.
18. Atanassov BS, Barrett JC, Davis BJ (2005) Homozygous germ line mutation in exon 27 of murine Brca2 disrupts the Fancd2-Brca2 pathway in the homologous recombination-mediated DNA interstrand cross-links' repair but does not affect meiosis. Genes Chromosomes Cancer 44:429-37.
19. Peng M, Litman R, Jin Z, Fong G, Cantor SB (2006) BACH1 is a DNA repair protein supporting BRCA1 damage response. Oncogene 25:2245-53.
20. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 273:5858-68.
21. Niedernhofer LJ, et al. (2004) The structure-specific endonuclease Ercc1-Xpf is required to resolve DNA interstrand cross-link-induced double-strand breaks. Mol. Cell Biol. 24:5776-87.
22. Brown KD, et al. (1997) The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. Proc. Natl. Acad. Sci. U. S. A. 94:1840-5.
23. Gueven N, Fukao T, Luff J, Paterson C, Kay G, Kondo N, Lavin MF (2006) Regulation of the Atm promoter in vivo. Genes Chromosomes Cancer 45:61-71.
24. Berkovich E, Ginsberg D (2003) ATM is a target for positive regulation by E2F-1. Oncogene 22:161-7.
25. Peng Y, et al. (2005) Deficiency in the catalytic subunit of DNA-dependent protein kinase causes down-regulation of ATM. Cancer Res. 65:1670-7.
26. Kurz EU, Lees-Miller SP (2004) DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst) 3:889-900.
27. Futaki M, et al. (2002) The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage. Carcinogenesis 23:67-72.
28. Futaki M, Liu JM (2001) Chromosomal breakage syndromes and the BRCA1 genome surveillance complex. Trends Mol. Med. 7:560-5.
29. Levitus M, et al. (2005) The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J. Nat. Genet. 37:934-5.
30. Levran O, et al. (2005) The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat. Genet. 37:931-3.
31. Bridge WL, Vandenberg CJ, Franklin RJ, Hiom K (2005) The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat. Genet. 37:953-7.
32. Todaro GJ, Green H, Swift MR (1966) Susceptibility of human diploid fibroblast strains to transformation by SV40 virus. Science 153:1252-4.
33. Liu JM, Poiley J, Devetten M, Kajigaya S, Walsh CE (1996) The Fanconi anemia complementation group C gene (FAC) suppresses transformation of mutant fibroblasts by the SV40 virus. Biochem. Biophys. Res. Commun. 223:685-90.
34. Freie B, et al. (2003) Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. Blood 102:4146-52.
35. Houghtaling S, et al. (2005) Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Cancer Res. 65:85-91.
36. Liu TX, et al. (2003) Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis. Dev. Cell 5:903-14.
37. Kennedy RD, et al. (2007) Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated. J. Clin. Invest 117:1440-9.
38. van der Heijden MS, Yeo CJ, Hruban RH, Kern SE (2003) Fanconi anemia gene mutations in young-onset pancreatic cancer. Cancer Res. 63:2585-8.
39. van der Heijden MS, et al. (2004) Functional defects in the Fanconi anemia pathway in pancreatic cancer cells. Am. J. Pathol. 165:651-7.